{"preliminary_commentary":{"by_channel":{"x_thread":6,"youtube":4,"podcast":2},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT03233711\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"name":"EA2165","nct_id":"NCT03233711","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=ea2165-nct03233711. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Patients receive nivolumab while on study. Patients undergo sigmoidoscopy, colonoscopy or anoscopy, proctoscopy or digital rectal exam, x-ray, CT scan, MRI, biopsy and blood sample collection throughout the study.","label":"Arm A (nivolumab)","type":"EXPERIMENTAL"},{"description":"Patients undergo observation while on study. Patients undergo sigmoidoscopy, colonoscopy or anoscopy, proctoscopy or digital rectal exam, x-ray, CT scan, MRI, biopsy and blood sample collection throughout the study.","label":"Arm B (clinical observation)","type":"OTHER"}],"collaborators":["Canadian Cancer Trials Group"],"completion_date":{"date":"2027-12-31","type":"ESTIMATED"},"conditions":["Anal Basaloid Carcinoma","Anal Canal Cloacogenic Carcinoma","Anal Margin Squamous Cell Carcinoma","Stage IIB Anal Cancer AJCC v8","Stage III Anal Cancer AJCC v8"],"enrollment":{"count":344,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Biopsy Procedure","otherNames":["Biopsy","BIOPSY_TYPE","Bx"],"type":"PROCEDURE"},{"name":"Biospecimen Collection","otherNames":["Biological Sample Collection","Biospecimen Collected","Sample Collection","Specimen Collection"],"type":"PROCEDURE"},{"name":"Colonoscopy","otherNames":[],"type":"PROCEDURE"},{"name":"Computed Tomography","otherNames":["CAT","CAT Scan","Computed Axial Tomography","Computerized Axial Tomography","Computerized axial tomography (procedure)","Computerized Tomography","Computerized Tomography (CT) scan","CT","CT Scan","Diagnostic CAT Scan","Diagnostic CAT Scan Service Type","tomography"],"type":"PROCEDURE"},{"name":"Digital Rectal Examination","otherNames":["DRE"],"type":"PROCEDURE"},{"name":"High Resolution Anoscopy","otherNames":["HRA"],"type":"PROCEDURE"},{"name":"Magnetic Resonance Imaging","otherNames":["Magnetic Resonance","Magnetic Resonance Imaging (MRI)","Magnetic resonance imaging (procedure)","Magnetic Resonance Imaging Scan","Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance","MR","MR Imaging","MRI","MRI Scan","MRIs","NMR Imaging","NMRI","Nuclear Magnetic Resonance Imaging","sMRI","Structural MRI"],"type":"PROCEDURE"},{"name":"Nivolumab","otherNames":["ABP 206","BCD-263","BMS 936558","BMS-936558","BMS936558","CMAB819","MDX 1106","MDX-1106","MDX1106","NIVO","Nivolumab Biosimilar ABP 206","Nivolumab Biosimilar BCD-263","Nivolumab Biosimilar CMAB819","ONO 4538","ONO-4538","ONO4538","Opdivo"],"type":"BIOLOGICAL"},{"name":"Patient Observation","otherNames":["Active Surveillance","deferred therapy","expectant management","Observation","Watchful Waiting"],"type":"OTHER"},{"name":"Proctoscopy","otherNames":[],"type":"PROCEDURE"},{"name":"Sigmoidoscopy","otherNames":["Proctosigmoidoscopy"],"type":"PROCEDURE"},{"name":"X-Ray Imaging","otherNames":["Conventional X-Ray","Diagnostic Radiology","Medical Imaging, X-Ray","Plain film radiographs","Radiographic Imaging","Radiographic imaging procedure (procedure)","Radiography","RG","Static X-Ray","X-Ray"],"type":"PROCEDURE"}],"last_update":"2026-10-26","lead_sponsor":"National Cancer Institute (NCI)","official_title":"A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2027-12-31","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Disease free survival","timeFrame":"Up to 7 years"}],"references":[],"start_date":{"date":"2018-07-05","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer","url":"https://clinicaltrials.gov/study/NCT03233711"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/ea2165-nct03233711"}